ArticleAnnals of translational medicine2021

Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer.

Pauline Viviane Pocha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.